Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial

The concomitant use of RT with TMZ was well tolerated and resulted in significantly better progression-free survival of BM at 90 days. Although caution should be used, these results suggest TMZ could improve local control of BM.